Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development
By Maggie Fick LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely ...
AOL
Novo Nordisk partners with OpenAI to speed drug discovery
The race to develop the next generation of medicines just got faster. At least, that is the bet Novo Nordisk is making. The Danish pharmaceutical company announced a strategic partnership with OpenAI ...
NJBIZ
Novo Nordisk teams with OpenAI to speed drug development
Pharmaceutical giant Novo Nordisk is teaming with OpenAI to deploy artificial intelligence in an effort to speed up drug development. The Danish company said the collaborationwill pilot AI to analyze ...
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
The drugmaker said it would integrate OpenAI’s models across its operations to help analyze complex datasets and reduce the time it takes to move from research to delivering treatments.
Computer Weekly
Novo Nordisk partners with OpenAI to AI-power drug development
Danish pharmaceutical company Novo Nordisk has partnered with OpenAI to support drug research and development. Through the partnership, Novo Nordisk said it plans to deploy advanced artificial ...
MobiHealthNews
OpenAI partners with Novo Nordisk for AI drug discovery
OpenAI has announced a strategic partnership with pharma giant Novo Nordisk to use advanced AI for drug discovery, including analyzing complex datasets, identifying drug candidates and reducing the ...